Structural and molecular insights into the mechanism of resistance to enzalutamide by the clinical mutants in androgen receptor (AR) in castration-resistant prostate cancer (CRPC) patients
Abbas Khan, Yuanshen Mao, Sana Tahreem, Dong‐Qing Wei, Yanjing Wang
Topics & Concepts
EnzalutamideAndrogen receptorProstate cancerChemistryMutantMutationCancer researchCancerInternal medicineGeneBiologyBiochemistryMedicineProstate Cancer Treatment and ResearchMass Spectrometry Techniques and ApplicationsEstrogen and related hormone effects